Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIFT-02 trial of NTRA-9620 in infants with short bowel syndrome after bowel resection
MOH_2017-06-22_000549Phase 3Completed
- Sponsor
- Nutrinia
- Start
- Mar 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of NTRA-9620 in short bowel syndrome (SBS) (3 arms), sponsored by Nutrinia. Primary endpoints: Percent change in parenteral nutrition and Percent change in parenteral nutrition from baseline based on caloric intake. Started Mar 2017; status: completed.
02
Drugs
NTRA-9620
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on MOH_2017-06-22_000549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-06-22_000549.